Ning G

No ORCID on file · 5 papers in corpus · active 2010-2026

Study types

  • other 1

Condition tags

  • dysmenorrhea 1
  • endometriosis 1
2026
Communications medicine ·doi:10.1038/s43856-026-01379-y

BackgroundOvarian cancer is a major female reproductive health issue with heterogeneous biological features on its subtypes, which may require different therapeutic strategies. Glucagon-like peptide-1 receptor (GLP-1R) agonists were reporte…

2021
Translational andrology and urology ·doi:10.21037/tau-21-229

BackgroundPrevious study has been reported that COX4I2 expression level demonstrated a positive correlation with microvessel density in pheochromocytomas (PCC) samples, suggesting that the expression of COX4I2 maybe related to blood supply …

other 2017
Clinical radiology ·doi:10.1016/j.crad.2017.02.002

AIM: To outline the anatomical variations of obstructive reproductive tract anomalies (ORTA) using magnetic resonance imaging (MRI) and its role in preoperative evaluation. MATERIALS AND METHODS: MRI and treatment of 21 paediatric patients…

2013
The Journal of Pathology ·doi:10.1002/path.4263

It is currently hoped that deaths from extra-uterine high-grade serous cancer (HGSC) will be reduced via opportunistic salpingectomy in healthy women. Accumulated data implicate the fimbria as a site of origin and descriptive molecular path…

2010
The Journal of Pathology ·doi:10.1002/path.2739

The 'p53 signature' is a benign secretory cell outgrowth in the distal Fallopian tube that shares properties with ovarian serous cancer-including p53 mutations-and is a putative serous cancer precursor. We expanded the precursor definition …